Titlebook: Cardiac PET and PET/CT Imaging; Marcelo F. Carli (Chief of Nuclear Medicine, Co-Di Book 2007 Springer-Verlag New York 2007 Computed.Emissi

幼兒

Radiopharmaceuticals for Clinical Cardiac PET Imagingen low until recently. This was due to the limitation of PET imaging to research centers with a PET camera and a cyclotron, its great expense, and the lack of reimbursement for clinical PET studies. Another disincentive was lack of standardized software for cardiac PET image processing, display, or

蒸發(fā)

Iodinated Contrast Agents for Cardiac CTon, high-speed CT machinery to obtain detailed volumetric images of cardiac anatomy, coronary circulation, and great vessels. Most contrast-enhanced CT examinations in the West are performed with nonionic iodinated contrast media. However, adverse events still exist and consist of allergylike contra

AFFIX

CT Anatomy of the Heartent of patients with acquired and congenital heart disease. Certainly, the dramatic improvement in temporal resolution obtained using electrocardiogram (ECG)-gated multidetector CT scanning has set the stage for the implementation of this mature technology into the daily practice of cardiac medicine

血友病

小步舞

褪色

PET and Integrated PET/CT Myocardial Imaging Protocols and Quality Assuranceity of coronary artery stenoses. As a result, most clinical applications of myocardial perfusion imaging are performed in conjunction with stress testing. Exercise stress testing with single photon emission computed tomography (SPECT) is widely used in the evaluation of patients with known or suspec

MIRTH

Quantifying Myocardial Perfusion for the Assessment of Preclinical CADstructure and function of the upstream coronary circulation. Loss of myocytes, replacement fibrosis, and scar tissue formation are associated with regional reductions of blood flow at rest per unit mass. Conversely, regional flow at rest may also be diminished in the absence of structural alteration

隱藏

Assessing Atherosclerotic Burden with CT cardiovascular disease (CVD), CT angiography has a well-established role for the detection of luminal stenoses and aneurysms in various vascular territories such as the aorta, carotid, renal, and lower-extremity arteries. Although of indisputable value in clinical practice, such findings reflect an

柔軟

異端邪說(shuō)下

Integrated Assessment of Myocardial Perfusion and Coronary Angiography with PET/CTmic extent and physiologic severity of coronary atherosclerosis and obstructive disease in a single setting. It allows detection and quantification of the burden of the extent of calcified and noncalcified plaques, quantification of vascular reactivity and endothelial health, and identification of f